CASI Pharmaceuticals
CASI
#9639
Rank
HK$0.33 B
Marketcap
HK$21.40
Share price
5.31%
Change (1 day)
-54.99%
Change (1 year)

Revenue for CASI Pharmaceuticals (CASI)

Revenue in 2024 (TTM): HK$0.17 Billion

According to CASI Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is HK$0.17 Billion. In 2023 the company made a revenue of HK$0.26 Billion a decrease over the revenue in the year 2022 that were of HK$0.33 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CASI Pharmaceuticals from 1996 to 2024

20002005201020152020$0.1B$0.2B$0.3B$0.4B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) HK$0.17 B-34.99%
2023 HK$0.26 B-21.44%
2022 HK$0.33 B43.18%
2021 HK$0.23 B100.41%
2020 HK$0.11 B264.83%
2019 HK$32.17 M
2018 N/A
2017 N/A
2016 N/A-100%
2015 HK$0.36 M100.94%
2014 HK$0.18 M
2013 N/A-100%
2012 HK$5.18 M-65.58%
2011 HK$15.07 M-47.55%
2010 HK$28.74 M-29.85%
2009 HK$40.97 M
2005 HK$45.88 M1048.73%
2004 HK$3.99 M-67.29%
2003 HK$12.21 M33.11%
2002 HK$9.17 M-36.81%
2001 HK$14.51 M-49.3%
2000 HK$28.63 M-25.88%
1999 HK$38.63 M-4.1%
1998 HK$40.28 M8.31%
1997 HK$37.19 M9.3%
1996 HK$34.03 M